New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
iRhythm Technologies, Inc.
IRTC
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

3B

Medical - Devices

Next Earning date - 20 Feb 2025

3B

Medical - Devices

Next Earning date - 20 Feb 2025

110.00USD

Shape1.45 ( 1.34%)
sun-fogPre-market 106.81$arrow-left-down-3.19 (-2.90%)
Market Closed (as of Feb 07, 21:21 EDT)
favorite-chart

Relative Strenght

79
favorite-chart

Volume Buzz

4%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated February 11, 2025
1W -1.46 % 1M 15.76 % 3M 25.57 % 1Y -8.11 %

Key Metrics

Shape
  • Market Cap

    3.43B


  • Shares Outstanding

    31.30M


  • Share in Float

    30.69M


  • Dividende

    0


  • Earning Date

    20 Feb 2025


  • Price Target

    109.5


  • Average Volume

    384681.7


  • Beta

    1.229


  • Range

    55.92-124.115


  • Industry

    Medical - Devices


  • Website

    https://www.irhythmtech.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

IRTC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$679M

Shape361%

2025-Revenue

$1.87

Shape-27%

2025-EPS

$133M

Shape-266%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

120.00(9.59%)

Number of analyst

1

Last analyst upgrade/downgrade

Goldman Sachs

initialise

Previous: Not converted

2024-10-04

Now: Neutral

Wolfe Research

upgrade

Previous: Not converted

2024-06-20

Now: Outperform

Stephens

initialise

Previous: Not converted

2023-02-07

Now: Overweight

UBS

initialise

Previous: Not converted

2023-02-07

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.67
vs -1.10

Q1.23

arrow
arrow

N/A

-1.29
vs -0.80

Q2.23

arrow
arrow

N/A

-0.61
vs -0.79

Q3.23

arrow
arrow

N/A

-0.89
vs -0.63

Q4.23

arrow
arrow

N/A

-1.26
vs -0.67

Q1.24

arrow
arrow

N/A

NA
vs -1.29

Q2.24

arrow
arrow

N/A

-0.61
vs -0.61

Q3.24

arrow
arrow

N/A

-1.26
vs -0.89

Q4.24

arrow
arrow

N/A

-0.33
vs -1.26

Q1.25

arrow
arrow

N/A

-0.69
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+38%

112.6M  vs 81.8M

Q1.23

arrow
arrow

+21%

111.4M  vs 92.4M

Q2.23

arrow
arrow

+22%

124.1M  vs 102.1M

Q3.23

arrow
arrow

+20%

124.6M  vs 103.9M

Q4.23

arrow
arrow

+18%

132.5M  vs 112.6M

Q1.24

arrow
arrow

+18%

131.9M  vs 111.4M

Q2.24

arrow
arrow

+19%

148M  vs 124.1M

Q3.24

arrow
arrow

+18%

147.5M  vs 124.6M

Q4.24

arrow
arrow

+19%

158.1M  vs 132.5M

Q1.25

arrow
arrow

+17%

153.9M  vs 131.9M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-8%

-0.08
vs -0.09

Q1.23

arrow
arrow

-18%

-0.18
vs -0.08

Q2.23

arrow
arrow

-8%

-0.08
vs -0.18

Q3.23

arrow
arrow

-12%

-0.12
vs -0.08

Q4.23

arrow
arrow

-18%

-0.18
vs -0.12

Q1.24

arrow
arrow

-51%

-0.51
vs -0.18

Q2.24

arrow
arrow

-20%

-0.20
vs -0.51

Q3.24

arrow
arrow

-64%

-0.64
vs -0.20

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

218

218
vs 246

-11%

Q1.23

arrow
arrow

224

224
vs 218

3%

Q2.23

arrow
arrow

216

216
vs 224

-4%

Q3.23

arrow
arrow

245

245
vs 216

13%

Q4.23

arrow
arrow

237

237
vs 245

-3%

Q1.24

arrow
arrow

268

268
vs 237

13%

Q2.24

arrow
arrow

240

240
vs 268

-10%

Q3.24

arrow
arrow

263

263
vs 240

10%

Earnings Growth

Latest News